Takeda Pharmaceuticals U.S.A., Inc.
Takeda Pharmaceuticals U.S.A., Inc., a subsidiary of Takeda Pharmaceutical Company Limited, is a leading global biopharmaceutical firm headquartered in the United States. Established in 1781, Takeda has evolved into a powerhouse in the pharmaceutical industry, focusing on areas such as oncology, gastroenterology, neuroscience, and rare diseases. With a commitment to innovation, Takeda offers a diverse portfolio of core products, including advanced therapies that address unmet medical needs. The company is recognised for its patient-centric approach and dedication to research and development, which has led to significant breakthroughs in treatment options. As a prominent player in the biopharmaceutical sector, Takeda has achieved notable milestones, including strategic acquisitions and partnerships that enhance its market position. With a strong presence in North America and beyond, Takeda Pharmaceuticals continues to shape the future of healthcare through its unwavering commitment to improving patient outcomes.
DitchCarbon Score
How does Takeda Pharmaceuticals U.S.A., Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Takeda Pharmaceuticals U.S.A., Inc.'s score of 54 is higher than 89% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Takeda Pharmaceuticals U.S.A., Inc.'s reported carbon emissions
Takeda Pharmaceuticals U.S.A., Inc. currently does not provide specific carbon emissions data for the most recent year, as there are no available figures reported in kg CO2e. Additionally, there are no documented reduction targets or climate pledges outlined in their initiatives. This absence of data suggests that while Takeda may be engaged in sustainability efforts, specific commitments or measurable achievements regarding carbon emissions reduction are not publicly available at this time. As a leading player in the pharmaceutical industry, Takeda's climate commitments may align with broader industry trends focusing on sustainability and reducing environmental impact, but further details are needed to assess their specific actions and targets.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Takeda Pharmaceuticals U.S.A., Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
